Blood clot prevention: which strategy saves most lives and money?
NCT ID NCT07455253
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of 234 women who had gynecological surgery to see which method of preventing blood clots (like using compression devices or blood thinners) works best and is most cost-effective. Researchers will compare different prevention strategies to find the optimal balance between safety and cost. The goal is to provide evidence that helps doctors choose the right prevention plan for each patient.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help hospitals choose the most cost-effective way to prevent dangerous blood clots after gynecological surgery, potentially saving lives and money.
- What could go wrong
- This is a retrospective study, not a controlled trial, so results may be less reliable. It only looks at past data from one hospital, so findings might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 234 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Female patients undergoing inpatient gynecological surgery at our center between Jan 1, 2021, and Dec 30, 2025
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female patients aged $\\ge$ 18 years. Underwent inpatient gynecological surgery (benign or malignant indications). Postoperative Caprini risk score $\\ge$ 2. Complete medical and billing records available in the hospital information system. Exclusion Criteria: * Diagnosis of VTE prior to the current surgery. Currently receiving therapeutic anticoagulation for other medical conditions (e.g., atrial fibrillation, mechanical heart valves). Inferior vena cava filter placement prior to surgery. Incomplete key clinical or financial data.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Deep vein thrombosis (DVT) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Nantong University
Nantong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler blood thinner shield cancer patients from new clots?
- Can a phone app stop deadly clots from coming back?
- Can electronic alerts and patient teaching stop deadly clots after cancer surgery?
- Can a new Five-Category system predict which pulmonary embolism patients will crash?
- Can we predict who dies from blood clots? a 100,000-Patient study searches for clues
- Can a tiny device suction out dangerous blood clots?